Skip to content

Outcome of onlay patellofemoral arthroplasty comparing resurfaced and unresurfaced patellae , a randomized controlled study.

Outcome of onlay patellofemoral arthroplasty comparing resurfaced and unresurfaced patellae , a randomized controlled study.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300073927
Enrollment
Unknown
Registered
2023-07-25
Start date
2023-08-01
Completion date
Unknown
Last updated
2023-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patellofemoral arthritis

Interventions

Group with resurfaced patella:patella resurfacing
Group with unresurfaced patella:patella unresurfacing

Sponsors

Renji Hospital, School of Medicine,Shanghai Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 79 Years

Inclusion criteria

Inclusion criteria: The cases of unilateral patellofemoral arthritis (KL grade III-IV) or patellofemoral cartilage injury (Outerbridge grade III-IV), for which conservative treatment has failed

Exclusion criteria

Exclusion criteria: age < 18y OR = 80y, inflammatory arthropathy, tibiofemoral arthritis, severe patellofemoral dysplasia, osteonecrosis or osteolysis of the patella, subchondral bone defect of the patella, joint infection, undergone knee surgery (except arthroscopic exploration), history of patellar fracture, knee ankylosis, extra-articular deformity, ligament injury of the knee joint, breakage of knee extension device, persons without civil capacity or with limited civil capacity.

Design outcomes

Primary

MeasureTime frame
Kujala score;

Secondary

MeasureTime frame
Revision rate;OKS score;KOOS score;WOMAC score;SF-36;VAS score;patient satisfaction;

Countries

China

Contacts

Public ContactXin Weiwei

Renji Hospital, School of Medicine,Shanghai Jiaotong University

xinweiwei@renji.com+86 136 3669 5122

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026